During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza Netherlands, leaders and innovators from the industry look the stage for a panel discussion around process development and commercial readiness for cell & gene therapy manufacturing.


Anthony Davies, Chair, CEO, Dark Horse Consulting

Felix Hermann, Vice President of CMC, Cimeio Therapeutics

Chaminda Salgado, Vice President of CMC, T-Cypher Bio

Erik Rutjens, Chief Technical Officer, CanCell Therapeutics

Behnam Ahmadian Baghbaderani, Global Head of CGT Process Development

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center